180 related articles for article (PubMed ID: 1865359)
1. Caffeine and theophylline as adenosine receptor antagonists in humans.
Biaggioni I; Paul S; Puckett A; Arzubiaga C
J Pharmacol Exp Ther; 1991 Aug; 258(2):588-93. PubMed ID: 1865359
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of the cardiovascular effects of adenosine by caffeine or 8-(p-sulfophenyl)theophylline.
Evoniuk G; von Borstel RW; Wurtman RJ
J Pharmacol Exp Ther; 1987 Feb; 240(2):428-32. PubMed ID: 3806407
[TBL] [Abstract][Full Text] [Related]
3. Caffeine withdrawal: apparent heterologous sensitization to adenosine and prostacyclin actions in human platelets.
Paul S; Kurunwune B; Biaggioni I
J Pharmacol Exp Ther; 1993 Nov; 267(2):838-43. PubMed ID: 8246157
[TBL] [Abstract][Full Text] [Related]
4. Modulation of the behavioral effects of chlordiazepoxide by methylxanthines and analogs of adenosine in squirrel monkeys.
Coffin VL; Spealman RD
J Pharmacol Exp Ther; 1985 Dec; 235(3):724-8. PubMed ID: 2416907
[TBL] [Abstract][Full Text] [Related]
5. Respiratory effects of xanthines and adenosine analogs in rhesus monkeys.
Howell LL; Morse WH; Spealman RD
J Pharmacol Exp Ther; 1990 Sep; 254(3):786-91. PubMed ID: 2395111
[TBL] [Abstract][Full Text] [Related]
6. Adenosine inhibits the rise in intracellular calcium and platelet aggregation produced by thrombin: evidence that both effects are coupled to adenylate cyclase.
Paul S; Feoktistov I; Hollister AS; Robertson D; Biaggioni I
Mol Pharmacol; 1990 Jun; 37(6):870-5. PubMed ID: 2359405
[TBL] [Abstract][Full Text] [Related]
7. Influence of adenosinergic drugs on ethanol withdrawal syndrome in rats.
Malec D; Michalska E; Pikulicka J
Pol J Pharmacol; 1996; 48(6):583-8. PubMed ID: 9112697
[TBL] [Abstract][Full Text] [Related]
8. Characterization of adenosine receptors in human erythroleukemia cells and platelets: further evidence for heterogeneity of adenosine A2 receptor subtypes.
Feoktistov I; Biaggioni I
Mol Pharmacol; 1993 Jun; 43(6):909-14. PubMed ID: 8391117
[TBL] [Abstract][Full Text] [Related]
9. Adenosine receptor-mediated modulation of dopamine release in the nucleus accumbens depends on glutamate neurotransmission and N-methyl-D-aspartate receptor stimulation.
Quarta D; Borycz J; Solinas M; Patkar K; Hockemeyer J; Ciruela F; Lluis C; Franco R; Woods AS; Goldberg SR; Ferré S
J Neurochem; 2004 Nov; 91(4):873-80. PubMed ID: 15525341
[TBL] [Abstract][Full Text] [Related]
10. Behavioral characterization of caffeine and adenosine agonists during chronic caffeine exposure.
Newland MC; Brown K
Behav Pharmacol; 1997 Feb; 8(1):17-30. PubMed ID: 9832997
[TBL] [Abstract][Full Text] [Related]
11. [3H]CGS 21680, a selective A2 adenosine receptor agonist directly labels A2 receptors in rat brain.
Jarvis MF; Schulz R; Hutchison AJ; Do UH; Sills MA; Williams M
J Pharmacol Exp Ther; 1989 Dec; 251(3):888-93. PubMed ID: 2600819
[TBL] [Abstract][Full Text] [Related]
12. Renal actions of a new adenosine agonist, CGS 21680A selective for the A2 receptor.
Levens N; Beil M; Jarvis M
J Pharmacol Exp Ther; 1991 Jun; 257(3):1005-12. PubMed ID: 2046017
[TBL] [Abstract][Full Text] [Related]
13. Reversal of the antiinflammatory effects of methotrexate by the nonselective adenosine receptor antagonists theophylline and caffeine: evidence that the antiinflammatory effects of methotrexate are mediated via multiple adenosine receptors in rat adjuvant arthritis.
Montesinos MC; Yap JS; Desai A; Posadas I; McCrary CT; Cronstein BN
Arthritis Rheum; 2000 Mar; 43(3):656-63. PubMed ID: 10728760
[TBL] [Abstract][Full Text] [Related]
14. Psychomotor stimulant effects of methylxanthines in squirrel monkeys: relation to adenosine antagonism.
Spealman RD
Psychopharmacology (Berl); 1988; 95(1):19-24. PubMed ID: 3133696
[TBL] [Abstract][Full Text] [Related]
15. Effect of caffeine on cerebral blood flow response to somatosensory stimulation.
Meno JR; Nguyen TS; Jensen EM; Alexander West G; Groysman L; Kung DK; Ngai AC; Britz GW; Winn HR
J Cereb Blood Flow Metab; 2005 Jun; 25(6):775-84. PubMed ID: 15703695
[TBL] [Abstract][Full Text] [Related]
16. Differential antagonism of cardiac actions of adenosine by theophylline.
Bertolet BD; Belardinelli L; Avasarala K; Calhoun WB; Franco EA; Nichols WW; Kerensky RA; Hill JA
Cardiovasc Res; 1996 Nov; 32(5):839-45. PubMed ID: 8944814
[TBL] [Abstract][Full Text] [Related]
17. Caffeine treatment and withdrawal in mice: relationships between dosage, concentrations, locomotor activity and A1 adenosine receptor binding.
Kaplan GB; Greenblatt DJ; Kent MA; Cotreau-Bibbo MM
J Pharmacol Exp Ther; 1993 Sep; 266(3):1563-72. PubMed ID: 8371158
[TBL] [Abstract][Full Text] [Related]
18. Pharmacology of the new selective A2a adenosine receptor agonist 2-hexynyl-5'-N-ethylcarboxamidoadenosine.
Monopoli A; Conti A; Zocchi C; Casati C; Volpini R; Cristalli G; Ongini E
Arzneimittelforschung; 1994 Dec; 44(12):1296-304. PubMed ID: 7848347
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo pharmacological characterization of N6-cyclopentyl-9-methyladenine (N-0840): a selective, orally active A1 adenosine receptor antagonist.
Barrett RJ; May JM; Martin PL; Miller JR
J Pharmacol Exp Ther; 1993 Apr; 265(1):227-36. PubMed ID: 8386236
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic and neurohumoral effects of various grades of selective adenosine transport inhibition in humans. Implications for its future role in cardioprotection.
Rongen GA; Smits P; Ver Donck K; Willemsen JJ; De Abreu RA; Van Belle H; Thien T
J Clin Invest; 1995 Feb; 95(2):658-68. PubMed ID: 7860749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
